SIRION Biotech signs new research and licensing agreement for AAV capsid development with US Biotech company!

SIRION Biotech has ongoing research and licensing agreements with several global pharma and biotech companies and is very pleased to add another US company to its partners. SIRION AAV evolution projects are carried out in our Heidelberg laboratories, with vector manufacture taking place in our specialized Graefelfing production facility. Details of the deal have not been disclosed.